russ2000_1830|DERM|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
russ2000_1830|DERM|1|Journey Medical Corp Total Current Assets (Quarterly) (USD)|Journey Medical Corp Cash and Short Term Investments (Quarterly) (USD)|Journey Medical Corp Inventories (Quarterly) (USD)|Journey Medical Corp Net PP&E (Quarterly) (USD)|Journey Medical Corp Goodwill and Intangibles (Quarterly) (USD)|Journey Medical Corp Total Liabilities (Quarterly) (USD)|Journey Medical Corp Total Current Liabilities (Quarterly) (USD)|Journey Medical Corp Total Long Term Liabilities (Quarterly) (USD)|Journey Medical Corp Total Deposits (Quarterly) (USD)|Journey Medical Corp Book Value (Quarterly) (USD)|Journey Medical Corp Retained Earnings (Quarterly) (USD)|Journey Medical Corp Treasury Stock (Quarterly) (USD)|Journey Medical Corp EV to Revenues|Journey Medical Corp EV to Earnings|Journey Medical Corp EV to Free Cash Flow|Journey Medical Corp EV to Assets (Quarterly)|Journey Medical Corp PS Ratio|Journey Medical Corp PE Ratio|Journey Medical Corp Price to Book Value|Journey Medical Corp PEG Ratio|Journey Medical Corp Debt to Equity Ratio|Journey Medical Corp Dividend Yield|Journey Medical Corp Shareholder Yield (TTM)|Journey Medical Corp Percent of Shares Outstanding Short|Journey Medical Corp Total Receivables (Quarterly) (USD)|Journey Medical Corp Total Payables (Quarterly) (USD)|Journey Medical Corp Total Capital Stock (Quarterly) (USD)|Journey Medical Corp Return on Invested Capital|Journey Medical Corp Quality Ratio Score|Journey Medical Corp Momentum Score|Journey Medical Corp Beta (1Y)|Journey Medical Corp Sustainable Growth Rate (TTM)|Journey Medical Corp Institutional Investor Ownership Percentage|Journey Medical Corp Average Diluted Shares Outstanding (Quarterly)|Journey Medical Corp Total Employees (Annual)|Journey Medical Corp EPS Diluted (Quarterly) (USD)|Journey Medical Corp SG&A Expense (Quarterly) (USD)|Journey Medical Corp Shares Outstanding|Journey Medical Corp Repurchase of Capital Stock (Quarterly) (USD)|Journey Medical Corp Ordinary Shares Number (Quarterly)|Journey Medical Corp Payout Ratio|Journey Medical Corp Quick Ratio (Quarterly)|Journey Medical Corp Normalized Diluted EPS (Quarterly) (USD)|Journey Medical Corp Stock Buybacks (Quarterly) (USD)|Journey Medical Corp Effective Tax Rate (TTM)|Journey Medical Corp Return on Equity|Journey Medical Corp Net Income (TTM) (USD)|Journey Medical Corp Revenue (TTM) (USD)|Journey Medical Corp Dividend Per Share (Quarterly) (USD)|Journey Medical Corp Revenue (Quarterly) (USD)|Journey Medical Corp Gross Profit (Quarterly) (USD)|Journey Medical Corp Pre-Tax Income (Quarterly) (USD)|Journey Medical Corp Net Income (Quarterly) (USD)|Journey Medical Corp Net Interest Income (Quarterly) (USD)|Journey Medical Corp Price (USD)|Journey Medical Corp Total Return Price (USD)|Journey Medical Corp Enterprise Value (USD)|Journey Medical Corp 30-Day Average Daily Volume|Journey Medical Corp 1 Year Price Returns (Daily)|Journey Medical Corp Short Interest|Journey Medical Corp PE Ratio (Forward)|Journey Medical Corp PE Ratio (Forward 1y)|Journey Medical Corp PS Ratio (Forward)|Journey Medical Corp PS Ratio (Forward 1y)|Journey Medical Corp Quarterly EPS Estimates (USD)|Journey Medical Corp Quarterly Revenue Estimates (USD)|Journey Medical Corp Quarterly EPS Surprise|Journey Medical Corp Quarterly Revenue Surprise|Journey Medical Corp Quarterly Actual EPS (USD)|Journey Medical Corp Quarterly Actual Revenue (USD)|Journey Medical Corp Revenue Estimates for Current Fiscal Year (USD)|Journey Medical Corp Revenue Estimates for Next Fiscal Year (USD)|Journey Medical Corp Price Target (USD)|Journey Medical Corp Consensus Recommendation|Journey Medical Corp Price Target Num Estimates|Journey Medical Corp EPS Estimates for Current Fiscal Year (USD)|Journey Medical Corp EPS Estimates for Next Fiscal Year (USD)|Journey Medical Corp Research and Development Expense (Quarterly) (USD)|Journey Medical Corp Reconciled Depreciation (Quarterly) (USD)|Journey Medical Corp Non-Operating Interest Expense (Quarterly) (USD)|Journey Medical Corp Land and Improvements (Quarterly) (USD)|Journey Medical Corp Buildings and Improvements (Quarterly) (USD)|Journey Medical Corp Other Properties (Quarterly) (USD)|Journey Medical Corp Machine, Furniture & Equipment (Quarterly) (USD)||
russ2000_1830|DERM|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
russ2000_1830|DERM|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_1830|DERM|5|136.5|136.5|136.5|136.5|136.5|136.5|136.5|136.5||136.5|136.5||1.46268656716||1.46268656716||1.46268656716||||136.5|1.46268656716||15.4|136.5|136.5|136.5||||||31|114.25||114.25|114.25|18.5||136.5|92|136.5|114.25||92||92|92||114.25|114.25|114.25|114.25|114.25|1.46268656716|1.46268656716|1.46268656716|1.39473684211||15.4|||1.44117647059|1.44117647059||91.4|||||9.25|12.3333333333|23|17.25|23|||114.25|121.666666667|114.25|||136.5|||
russ2000_1830|DERM|6|2|2|2|2|2|2|2|2||2|2||67||67||67||||2|67||5|2|2|2||||||1|4||4|4|2||2|1|2|4||1||1|1||4|4|4|4|4|67|67|67|38||5|||34|34||5|||||4|3|3|4|3|||4|3|4|||2|||
russ2000_1830|DERM|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_1830|DERM|202006||||||||||||||||||||||||||||||||||16.4412||0.0277|4.752||||||0.0277|||||||9.415|6.291|1.384|0.455|-0.155||||||||||||||||||||||||||0.155||||||
russ2000_1830|DERM|202009||||||||||||||||||||||||||||||||||16.4412||0.0018|5.829||||||0.0018|||||||9.447|6.068|0.052|0.029|-0.187|||||||||||||||||||||||||0.379|0.187||||||
russ2000_1830|DERM|202012|35.242|8.246|1.404|0.175|15.029|41.614|28.061|13.553||10.292|5.12||||||||||0.5072||||23.928|4.638|0.001|||||||16.4412||0.1522|5.816|||15.7794||1.1466|0.1522|||||||13.723|9.442|3.42|2.502|-0.206|||||||||||||||||||||||||0.379|0.206|||0.175|||
russ2000_1830|DERM|202106|53.473|12.176|14.315|0.133|13.701|73.517|44.409|29.108||-0.792|-6.477||||||||||-6.6225||||26.193|7.93|0.001|||||||16.4412|82|-0.722|7.795|||15.7794||0.864|-0.7134||14.8787||-8.879|47.873||15.288|7.804|-15.287|-11.865|-1.342||||||||||||||||||||||||13.772||1.342|||0.133|||
russ2000_1830|DERM|202109|66.795|21.689|11.614|0.111|13.043|100.768|59.79|40.978||-11.709|-17.123||2.1239||-32.2439||2.2171||||-1.2787|||0.072|31.738|33.276|0.001|-258.0506|7|||||15.7794||-0.6747|10.755|16.4412||15.7794||0.8936|-0.6746||22.666||-19.98|58.068||19.61|8.443|-14.021|-10.646|-1.373|7.91|7.91|123.3329|||11845||||||19.456||0.7915||19.61||||||||0.794|0.68|1.373|||0.111|||
russ2000_1830|DERM|202112|||||||||||||1.4278||-21.6762||1.508|||||||0.0539|||||||||0.1911|||||16.6596|||||||||||||||||5.38|5.38|82.9116|62091.2333||8979|||0.8339|0.7265||20.75|||||66.348|92.4245|14.5|1.5|2||||||||||5.34|5.41
russ2000_1830|DERM|202203||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||23.133||||||||||||||||||||
russ2000_1830|DERM|202206||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||26.495||||||||||||||||||||
russ2000_1830|DERM|202209||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||27.812||||||||||||||||||||
russ2000_1830|DERM|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||29.144||||||||||||||||||||